OR WAIT 15 SECS
Launching a product soon? Here’s how to think about strategy and design for your patient services program.
Setting up patient services programs is a critical endeavor that can help make or break a product launch and the ongoing success of a product during “normal” times. In the wake of the novel coronavirus pandemic and increasingly uncertain coverage scenarios, the role of hub services is even more critical for pharmaceutical and biotech companies to ensure patient access to therapy and to help patients navigate the healthcare system.
When well-designed, these programs tailor services to make it easier for patients to learn about and receive appropriate care, with services that may include disease state education, support for understanding insurance coverage and financial assistance for those in need.
Understanding no one-size-fits-all template for patient services programs exists, this article provides best-practice guidance on choosing your support service model, as well as design and implementation strategies.
As you prepare to launch your product, one of the most important steps is to determine which hub model to implement. Should your team rely wholly on a third-party, a hybrid of outsourced and in-sourced components, or all in-house resources?
To begin, based on your product strategy, potential patient pool, and planned services to be built into your program, assess the infrastructure needs of hosting and managing a patient services support program, spanning:
Then, weigh those needs against your current organizational structure, as well as the intended focus of your enterprise and the product being launched to identify the hub model that best fits your organization.
Let’s say your enterprise is focused on science and delivery of novel life-changing therapies and the product you are preparing to launch is an oral oncolytic. An outsourced model might be ideal in this situation because it will provide the people, process, and technology to support your launch, while your team focuses on research and development. In this case, you will need to find the right vendor based on the combination of capabilities needed (such as bridge program and financial assistance) and the account management approach (such as dedicated staff and partnership strategy). While the vendor’s capabilities should align with the product need and the intended services to be provided to customers, the account management approach needs to align with what your team expects for day-to-day operations, strategic oversight, compliance requirements, and vendor/client communication plan.
For example, a fully outsourced model for a physician-administered ophthalmology product that included reimbursement support and financial assistance enlisted a right-sized vendor to implement and run the day-to-day patient services program. As part of the strategic oversight plan, the manufacturer actively monitored and audited the program’s success through vendor-facilitated daily activity reports, weekly meetings to track progress against goals, and quarterly business review meetings of the overall program progress against milestones. This approach enabled the manufacturer to be confident the program was meeting its organizational goals and product strategy without the need to execute the hub services themselves. It also enabled them to adjust the services support as necessary.
For comparison, a hybrid model includes some services to be administered in-house, while others are outsourced. This model should be developed based on in-house infrastructure and skill set, as well as the desired customer experience. For example, in a recent case, the manufacturer preferred to keep the customer relationship management in-house, so decided to focus on front end customer support and outsource payer-related services like benefits verification and prior authorization. In a hybrid model, the integration of people, process and technology is important. You want to be sure your in-house and outsourced functions own and are accountable for their respective areas, have proper hand-offs between the two functions, and are working consistently and collaboratively to create a positive patient experience.
Some manufacturers prefer to manage the patient services support entirely inhouse. The advantage of this approach is it enables you to tightly control every aspect of the product experience. The disadvantage is it requires having the necessary infrastructure, as well as the ability to develop and maintain the people, processes and technologies required to fully support the program. This may work well when the target patient population is particularly small, or when the product is nuanced and has complexities in the manufacturing or distribution process. In addition, some large manufacturers elect to keep everything inhouse, especially in cases where past outsourced experiences delivered underwhelming or even negative patient experiences.
Once your team determines the model that best aligns with your organizational goals, product strategy and infrastructure, you can begin designing the patient services program. Here, it will be important to map the patient and provider journeys to determine and address any potential barriers to access. The design strategy should at once 1) help the right patients learn about the therapy option, its potential benefits to them, and the hub program offering and requirements, as well as 2) be convenient for clinicians to refer into, work within, and rely on to facilitate patient access and clinical outcomes. Depending on the therapy, key service offerings might include:
For example, in one recent case, a manufacturer of an oncology product with a REMS created a full suite of reimbursement, patient financial and adherence support services to be able to address manufacturing specificity, multiple patient touchpoints, care coordination, provider requirements for receiving and administering the product, and ensuring coverage and access according to payer policies. For comparison, a product in the rare disease space implemented only reimbursement support and patient financial assistance for its hub program, because the therapy is administered in a controlled hospital setting in which adherence poses little risk.
Once the service components of your program are determined, begin developing the program. As a first step, thoroughly document program design parameters and key decisions, including program objectives, compliance considerations, program communication tactics and service offerings.
As part of the design and development, also consider the other tactics your program will need to support the product launch, new service implementations, as well as to drive stakeholder collaboration, such as:
Once the components and support tactics are planned, be sure to define metrics to track and assess program performance, and create a process to monitor and report metrics against KPIs. Also, define actionable analytics for the report to be sure the right information is included, and create a process and plan to implement necessary changes based on results and learnings. It is also important to plan ongoing compliance reviews for marketing materials and correspondence templates.
A systematic approach for program management will ensure that issues are identified, mediated and course corrected early in order to support long-term success. Your measurement tools should be used to monitor the progress and performance of the program, as well as to identify opportunities for improvement. With this in mind, build the program around the concept of continuous process improvement and plan for evolution. To do this, plan to perform audits and regular monitoring to ensure operations adhere to standards and perform in line with expectations, and that KPIs align with SOPs. Consider incorporating independent audits to help reveal discrepancies or catch when the program evolves or strays. The key areas of program operations for improvements commonly may include:
Another critical design and implementation component is to incorporate and institutionalize effective strategies to build skills and motivate your team toward high performance. To this end, it is best to define a training plan that includes onboarding, program-specific service development, and ongoing training opportunities, such as for disease sensitivity and patient empathy. Also, put mechanisms in place to support the quality program and improvement initiatives. For example, invite and address associate feedback, hold regular team meetings and creating opportunities to share best practices and case studies.
Lastly, to ensure your patient services program’s best opportunity for success, make sure to identify, involve, and incent a cross-functional governance team to bring program information back. Ideally, these are the people connected to the business goals and objectives in position to execute (or at least influence) best practices and outcomes, e.g. representatives from the regulatory, compliance, marketing and brand, field, safety and pharmacoviligence, market access, and medical affairs teams. The more you can connect and involve this group, the better your patient services program will align with business goals and objectives, deliver on specific product and brand objectives, and be enabled to meet defined program objectives, including around patient access and customer support.
Again, these are strategic starting points and considerations for designing, implementing and evolving an effective and sustainable patient service support program. As the disruptive effects of the pandemic continue to reshape the global healthcare industry for patients, providers and payers, manufacturers will need to be agile in adapting to and addressing the shifting landscape, especially as more patients become underinsured and/or lose coverage all together due to economic constraints. At the core, a strong program facilitates getting patients access to a therapy as conveniently and reliably as possible within the unique contexts of provider needs, payer requirements and market realities.
Dana Edwards is a director and lead for Patient Services in Life Sciences at Guidehouse.
Casey Horton is a director in Guidehouse’s Global Life Sciences Governance, Risk Management and Compliance practice.